Czechia – Antineoplastic and immunomodulating agents – LP s obsahem filgrastimu 2026

Decision signals

First-pass opportunity review

These signals are calculated from the indexed fields. They help prioritize a review but do not replace eligibility checks in the official procurement documents.

Timing signal

Deadline not indexed

Check the official notice

Indexed data completeness

100%

Based on seven decision fields

Official title coverage

7 languages

Preserved from source-supplied versions

Classification signal

33652000

Medical equipment, pharmaceuticals and personal care products

Official title versions

TED may publish the same notice title in several official languages. Biderra preserves the versions supplied in the source feed.

What Biderra adds

For notice 595427-2026, Biderra has normalized the contracting authority country as Czechia, grouped CPV 33652000 under pharma and laboratory, compared the available deadline fields with today, measured field completeness, and preserved 7 source-supplied title versions. The official record remains decisive.